Servier acquires non-Hodgkin B-cell lymphoma treatment PIXUVRI®...
Business Wire IndiaServier, an independent international pharmaceutical company, today announced the acquisition of PIXUVRI® from CTI BioPharma. PIXUVRI is a treatment for adult patients with mult...